Patents by Inventor Cecilia M. P. Rodrigues

Cecilia M. P. Rodrigues has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939353
    Abstract: The present invention relates to fluorinated and alkylated bile acids.
    Type: Grant
    Filed: July 16, 2021
    Date of Patent: March 26, 2024
    Assignee: Metselex, inc.
    Inventors: Michael Finch, Cyrus B. Munshi, Cecilia M. P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20220002339
    Abstract: The present invention relates to fluorinated and alkylated bile acids.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 6, 2022
    Inventors: Michael Finch, Cyrus B. Munshi, Cecilia M.P. Rodrigues, Susana Dias Lucas de Oliveira
  • Patent number: 11072630
    Abstract: The present invention relates to fluorinated and alkylated bile acids.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: July 27, 2021
    Assignee: Metselex, inc.
    Inventors: Michael Finch, Cyrus B. Munshi, Cecilia M. P. Rodrigues, Susana Dias Lucas de Oliveira
  • Patent number: 10144758
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the bile acids such as ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium. Also disclosed are pharmaceutical compositions and methods of using the deuterated bile acids.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: December 4, 2018
    Assignee: Metselex, Inc.
    Inventors: Michael D Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M. P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20180044373
    Abstract: The present invention relates to fluorinated and alkylated bile acids.
    Type: Application
    Filed: March 10, 2016
    Publication date: February 15, 2018
    Inventors: Michael Finch, Cyrus B. Munshi, Cecilia M.P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20180030084
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: July 17, 2017
    Publication date: February 1, 2018
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M.P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20150072967
    Abstract: Methods of preventing or retarding or reversing or abolishing the onset and preventing the onset of neurodegenerative disease are discussed. This is achieved through the administration of a bile acid, a salt of the bile acid, an analog of the bile acid or any combinations of these compounds. The bile acid abolishes or interferes or down-regulates metabolic pathways leading to the onset of neurodegenerative diseases. The bile acid also activates metabolic pathways leading to the slowing or reversing or complete abolishment of the progression of neurodegenerative disease.
    Type: Application
    Filed: March 19, 2013
    Publication date: March 12, 2015
    Applicant: Metselex, Inc.
    Inventors: Cecilia M.P. Rodrigues, Rudi D'Hooge
  • Publication number: 20080194531
    Abstract: The present invention provides methods for treating visual disorders. Exemplary visual disorders include macular degeneration, retinitis pigmentosa, glaucoma, and/or retinal degeneration.
    Type: Application
    Filed: February 8, 2006
    Publication date: August 14, 2008
    Inventors: Clifford J. Steer, Walter C. Low, Timothy W. Olson, Jeffrey H. Boatright, John M. Nickerson, Cecilia M.P. Rodrigues, Machelle T. Pardue
  • Patent number: 6544972
    Abstract: Methods for limiting apoptosis in a cell population by contacting such cells with a hydrophilic bile acid, such as ursodeoxycholic acid (UDCA), salts thereof, and analogs thereof (e.g., glyco- and tauro-ursodeoxycholic acid).
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: April 8, 2003
    Assignee: Regents of the University of Minnesota
    Inventors: Clifford J. Steer, Betsy T. Kren, Guangsheng Fan, Cecilia M. P. Rodrigues
  • Publication number: 20030044413
    Abstract: Methods for limiting apoptosis in a cell population by contacting such cells with a hydrophilic bile acid, such as ursodeoxycholic acid (UDCA), salts thereof, and analogs thereof (e.g., glyco- and tauro-ursodeoxycholic acid).
    Type: Application
    Filed: September 18, 2002
    Publication date: March 6, 2003
    Applicant: Regents of the University of Minnesota
    Inventors: Clifford J. Steer, Betsy T. Kren, Guangsheng Fan, Cecilia M.P. Rodrigues